DEBATE: Psychedelic Policy Is OVERHYPED? - Dr. Matt Johnson vs Kevin Sabet

The debate between Dr. Matt Johnson and Kevin Sabet on The Illusion of Consensus podcast exposes a deep rift in how psychedelics should be approached—scientific rigor versus political momentum. Sabet, a former White House drug policy advisor, argues that President Trump’s psychedelic executive order is dangerously premature, driven more by podcasters like Joe Rogan than evidence. He warns of a 'celebratory' tone that downplays Ibogaine’s cardiotoxicity and risks repeating past failures with ketamine and marijuana, where medical claims outpaced regulation. Johnson counters that the order isn’t an approval but a research accelerator—funding mechanisms like national priority vouchers and Right to Try pathways are essential to move science forward, especially given decades of NIH reluctance. He acknowledges hype in the field but insists that even modest effect sizes (comparable to SSRIs) are meaningful when the mechanism is novel. The core tension isn’t about whether psychedelics have potential, but whether we should let politics, celebrity influence, and fear of missing out override the slow, careful process of clinical validation.